KaloBios Closer To $14M Ch. 11 Funding Despite Shkreli Ties

Bankrupt pharmaceutical developer KaloBios came a step closer Monday to securing a needed $14 million package to fund its case and exit Chapter 11 when a Delaware judge approved a letter...

Already a subscriber? Click here to view full article